海创药业：2025年上半年净亏损6185.32万元

Group 1 - The company reported a revenue of 13.1671 million yuan for the first half of 2025, representing a year-on-year increase of 11,899.08% [1] - The net loss attributable to shareholders was 61.8532 million yuan, compared to a net loss of 100 million yuan in the same period last year [1]